Compositions and methods for lipid production

US10920233B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10920233-B2
Application numberUS-201715855237-A
CountryUS
Kind codeB2
Filing dateDec 27, 2017
Priority dateMay 3, 2013
Publication dateFeb 16, 2021
Grant dateFeb 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein, inter alia, are compositions, oleagnious organisms, and methods useful for producing lipids, lipid precursors, and/or oleochemicals.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a lipid, lipid precursor, or oleochemi cal comprising: 1) culturing a genetically modified Yarrowia lipolytica yeast cell in a growth medium; and 2) isolating said lipid, lipid precursor, or oleochemical; wherein the dry weight of said genetically modified yeast cell comprises greater than 60% wt/wt lipids, lipid precursors, and oleochemicals; wherein said genetically modified yeast cell comprises (i) a recombinant acvl- CoA:diacvlglvcerol acvltransferase 1 (DGA1) gene and a genetically modified lipid synthesis regulator (MGA2) gene, wherein said genetically modified MGA2 gene increases lipid production compared to a non-genetically modified MGA2 control; or (ii) a recombinant acvl-CoA:diacvlglvcerol acvltransferase 2 (DGA2) gene and a genetically modified lipid synthesis regulator (MGA2) gene, wherein said genetically modified MGA2 gene increases lipid production compared to a non-genetically modified MGA2 control; and wherein said lipid, lipid precursor, or oleochemical is not a sterol. 2. The method of claim 1 , wherein said growth medium comprises a majority carbon source selected from the group consisting of glucose, glycerol, xylose, fructose, mannose, ribose, sucrose, and lignocellulosic biomass. 3. The method of claim 1 , wherein said growth medium comprises lignocellulosic biomass as the majority carbon source. 4. The method of claim 1 , wherein said growth medium comprises cobalt, iron, magnesium, potassium, zinc, nickel, molybdenum, manganese, copper, or boron. 5. The method of claim 1 , wherein said growth medium comprises 5.77×10 −5 M to 1.73x10 −4 M cobalt, 0.001 M to 0.003 M magnesium, 4.52×10 −5 M to 1.35x10 −4 M potassium, 4.05×10 5 M to 1.22x10 −4 zinc, 3.55×10 −5 M to 1.06×10 −4 manganese, 9.07×10 −5 M to 2.91x10 −4 boron, 3.76×10 −5 M to 1.10×10 −4 molybdenum, 2.28×10 −5 M to 6.84×10 −5 nickel, 3.60×10 −5 M to 1.08x10 −4 iron, or 4.70×10 −5 M to 1.41x10 −4 copper. 6. The method of claim 1 , wherein said genetically modified MGA2 gene comprises at least one nucleotide modification. 7. The method of claim 1 , wherein said genetically modified MGA2 gene comprises SEQ ID NO: 51. 8. The method of claim 1 , wherein said genetically modified yeast cell further comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MEFI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene or a recombinant AMP Deaminase (AMPD) gene. 9. The method of claim 1 , wherein said genetically modified yeast cell comprises a genetically modified multifunctional enzyme (MEFI) gene and a genetically modified PEX10 Transcription Factor (PEX10) gene. 10. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene and a genetically modified PEX10 Transcription Factor (PEX10) gene. 11. The method of claim 1 , wherein said genetically modified yeast cell comprises a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene and a recombinant AMP Deaminase (AMPD) gene. 12. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene and a recombinant AMP Deaminase (AMPD) gene.

Assignees

Inventors

Classifications

  • Fungi {; Processes using fungi} · CPC title

  • Fungi isolates · CPC title

  • Fatty acids · CPC title

  • Lyases (4.) · CPC title

  • obtained from glyceride producing microorganisms, e.g. single cell oil · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10920233B2 cover?
Described herein, inter alia, are compositions, oleagnious organisms, and methods useful for producing lipids, lipid precursors, and/or oleochemicals.
Who is the assignee on this patent?
Univ Texas
What technology area does this patent fall under?
Primary CPC classification C12N15/815. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).